Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shu Xia
Observed names:
S. Xia,
SHU XIA,
Shu XIA
Institutions:
Tongji Hospital,
Huazhong University of Science and Technology
Observed institutions:
Qinghai University,
Tongji University,
Medical College of Wisconsin,
Qinghai University Affiliated Hospital,
Tongji Hospital,
Medical College of Wisconsin Cancer Center,
Huazhong University of Science and Technology
show all 7
ORCID:
0009-0002-6562-4204
Observed ORCID:
0009-0002-6562-4204
OpenAlex ID:
A5113884153
Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer
2014
·
Xiaoyi Huang
, Tiezheng Yuan
, et al.
·
European Urology
·
681
Prostate cancer risk locus at 8q24 as a regulatory hub by physical interactions with multiple genomic loci across the genome
2014
·
Meijun Du
, Tiezheng Yuan
, et al.
·
Human Molecular Genetics
·
61
PDF
Cell‐free DNA copy number variations in plasma from colorectal cancer patients
2017
·
Jian Li
, Rachel L. Dittmar
, et al.
·
Molecular Oncology
·
55
PDF
Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer
2015
·
Shu Xia
, Manish Kohli
, et al.
·
Oncotarget
·
49
PDF
Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls
2015
·
Shu Xia
, Chiang-Ching Huang
, et al.
·
Lung Cancer
·
47
Unveiling the Role of HGF/c-Met Signaling in Non-Small Cell Lung Cancer Tumor Microenvironment
2024
·
Shuxi Yao
, Xinyue Liu
, et al.
·
International Journal of Molecular Sciences
·
33
PDF
Knockdown of the Bcl-2 gene increases sensitivity to EGFR tyrosine kinase inhibitors in the H1975 lung cancer cell line harboring T790M mutation
2013
·
MAN ZOU
, SHU XIA
, et al.
·
International Journal of Oncology
·
28
PDF
Parallel Serial Assessment of Somatic Mutation and Methylation Profile from Circulating Tumor DNA Predicts Treatment Response and Impending Disease Progression in Osimertinib-Treated Lung Adenocarcinoma Patients
2019
·
Shu Xia
, Junyi Ye
, et al.
·
Translational Lung Cancer Research
·
25
PDF
Pregabalin attenuates docetaxel-induced neuropathy in rats
2012
·
Ping Peng
, Qingsong Xi
, et al.
·
Journal of Huazhong University of Science and Technology [Medical Sciences]
·
24
A new rat model of bone cancer pain produced by rat breast cancer cells implantation of the shaft of femur at the third trochanter level
2013
·
Qi Gui
, Chengcheng Xu
, et al.
·
Cancer Biology & Therapy
·
23
PDF
Prognostic Potential of Secreted Modular Calcium-Binding Protein 1 in Low-Grade Glioma
2021
·
Jing Wang
, Shu Xia
, et al.
·
Frontiers in Molecular Biosciences
·
22
Irinotecan-platinum combination therapy for previously untreated extensive-stage small cell lung cancer patients: a meta-analysis
2018
·
Fei Xu
, Xiaoli Ren
, et al.
·
BMC Cancer
·
18
PDF
Indirect comparison between immunotherapy alone and immunotherapy plus chemotherapy as first-line treatment for advanced non-small cell lung cancer: a systematic review
2020
·
Lingling Li
, Fei Xu
, et al.
·
BMJ Open
·
15
PDF
Pemetrexed/cisplatin as first-line chemotherapy for advanced lung cancer with brain metastases
2016
·
Guangzhao He
, Xiaoguang Xiao
, et al.
·
Medicine
·
15
Development and validation of a prognostic scale for hospitalized patients with terminally ill cancer in China
2013
·
Yu Huang
, Qingsong Xi
, et al.
·
Supportive Care in Cancer
·
14
Retrospective study of irinotecan/cisplatin followed by etoposide/cisplatin or the reverse sequence in extensive-stage small cell lung cancer
2015
·
Xiaoguang Xiao
, Shujing WANG
, et al.
·
OncoTargets and Therapy
·
12
PDF
Association between symptoms and their severity with survival time in hospitalized patients with far advanced cancer
2011
·
Yong Liu
, Qing-song Xi
, et al.
·
Palliative Medicine
·
12
CD1B is a Potential Prognostic Biomarker Associated with Tumor Mutation Burden and Promotes Antitumor Immunity in Lung Adenocarcinoma
2022
·
Zhou Li
, Yanqi Feng
, et al.
·
International Journal of General Medicine
·
11
PDF
The impact of UGT2B7 C802T and CYP3A4*1G polymorphisms on pain relief in cancer patients receiving oxycontin
2018
·
Jingwen Li
, Peng Peng
, et al.
·
Supportive Care in Cancer
·
11
Construction of a Novel Damage-Associated Molecular-Pattern-Related Signature to Assess Lung Adenocarcinoma’s Prognosis and Immune Landscape
2024
·
Xinyue Liu
, Shuxi Yao
, et al.
·
Biomolecules
·
9
PDF
MA01.09 Concomitant SBRT and EGFR-TKI Versus EGFR-TKI Alone for Oligometastatic NSCLC: A Multicenter, Randomized Phase II Study
2019
·
P. Peng
, Y. Chen
, et al.
·
Journal of Thoracic Oncology
·
8
PDF
Effect of antitumor therapy on cancer patients infected by SARS‐CoV‐2: A systematic review and meta‐analysis
2021
·
Piao Li
, Lingling Li
, et al.
·
Cancer Medicine
·
7
PDF
Compatibility of dexamethasone sodium phosphate with 5-HT3 receptor antagonists in infusion solutions: a comprehensive study
2016
·
Guangzhao He
, Fan Zeng
, et al.
·
European Journal of Hospital Pharmacy
·
7
Inhibiting PI3K/Akt pathway increases DNA damage of cervical carcinoma HeLa cells by drug radiosensitization
2010
·
Shu Xia
, Shiying Yu
, et al.
·
Journal of Huazhong University of Science and Technology [Medical Sciences]
·
7
The association between polymorphism of TNF-α gene and hypertensive disorder complicating pregnancy
2007
·
Yin Zhao
, Shu Xia
, et al.
·
Journal of Huazhong University of Science and Technology [Medical Sciences]
·
7
Show more works
View as search
Works count:
47
Citation count:
1,221
H-index:
14
I10-index:
19
Year
Topic
Type